Liquidia Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Jun 30 2026, Liquidia Corporation has not recorded any inventories.
Visit Liquidia Corporation Balance sheet

Within Healthcare sector 342 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1262 in the first quarter 2026, to 1849.

LQDA Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Liquidia Corporation Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

LQDA Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Inventory Growth	461.41 %	2013.12 %	9776.35 %	64463.16 %	-10.65 %
Y / Y Cost of Sales Growth	-	630.32 %	255.02 %	46.65 %	-86.27 %
Inventory Turnover Ratio (TTM)	-	0.88	0.63	0.66	2.3
LQDA's Total Ranking	# 1849	# 1262	# 1341	# 1184	# 1256
Average inventory processing period	-	413	580	553	159
Seq. Inventory Growth	26.91 %	19.76 %	-2.98 %	280.73 %	377.69 %
Seq. Cost of Sales Growth	-	130.48 %	109.46 %	1019.51 %	-86.49 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 105
Healthcare Sector	# 343
Overall Market	# 1849

Inventory Turnover Ratio Statistics
High	Average	Low
2.68	1.42	0.63
(Mar 31 2025)		(Dec 31 2025)

LQDA Company Profile >> Back to LQDA Efficiency Comparisons >> Compare LQDA Inventory Turnover Ratio to its Competitors

Financial Statements
Liquidia's Inventories	$ 36 Millions	Visit LQDA's Balance sheet
Liquidia's Cost of Revenues TTM	$ 18 Millions	Visit LQDA's Income Statement
What are LQDA's Sales?		Visit LQDA's Sales by Segment

Other Inventory Turnover Ratios
Liquidia's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
LQDA's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for LQDA's Competitors
Inventory Turnover Ratio for LQDA's Suppliers
Inventory Turnover Ratio for LQDA's Customers

You may also want to know
LQDA's Sales Growth Rates	LQDA's Pe Price to earnings ratio	LQDA's Receivables Turnover Ratio	LQDA's Stock Quote
LQDA's Net Income Growth Rates	LQDA's Ps Price to Sales ratio	LQDA's Sales per Employee	LQDA's Asset Turnover Ratio
LQDA's Net Margin	LQDA's Pb Price to Book ratio	LQDA's Financial Strength Ratios	LQDA's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Arcutis Biotherapeutics Inc	1.35	$ 41.096 Millions	$ 30 Millions
Alphatec Holdings Inc	1.32	$ 237.415 Millions	$ 179 Millions
Elanco Animal Health Incorporated	1.29	$ 2,241.000 Millions	$ 1,733 Millions
Xtant Medical Holdings Inc	1.28	$ 43.701 Millions	$ 34 Millions
Edwards Lifesciences Corporation	1.28	$ 1,443.400 Millions	$ 1,129 Millions
Globus Medical Inc	1.27	$ 989.145 Millions	$ 779 Millions
Karyopharm Therapeutics Inc	1.27	$ 4.942 Millions	$ 4 Millions
Clene Inc	1.25	$ 0.059 Millions	$ 0 Millions
Si bone inc	1.24	$ 44.462 Millions	$ 36 Millions
Kyntra Bio Inc	1.24	$ 4.444 Millions	$ 4 Millions
Pulmonx Corporation	1.24	$ 20.014 Millions	$ 16 Millions
Biolife Solutions Inc	1.24	$ 39.035 Millions	$ 32 Millions
Stereotaxis Inc	1.23	$ 13.184 Millions	$ 11 Millions
60 Degrees Pharmaceuticals Inc	1.20	$ 0.895 Millions	$ 1 Millions
Delcath Systems Inc	1.16	$ 12.355 Millions	$ 11 Millions
Bridgebio Pharma Inc	1.16	$ 39.655 Millions	$ 34 Millions
Neuropace Inc	1.14	$ 19.920 Millions	$ 17 Millions
Amarin Corp Plcuk	1.13	$ 108.346 Millions	$ 96 Millions
Treace Medical Concepts Inc	1.10	$ 42.186 Millions	$ 38 Millions
Corcept Therapeutics Inc	1.10	$ 14.085 Millions	$ 13 Millions
Zoetis Inc	1.08	$ 2,709.000 Millions	$ 2,505 Millions
Acadia Pharmaceuticals Inc	1.07	$ 100.979 Millions	$ 94 Millions
Bio Green Med Solution Inc	1.07	$ 1.244 Millions	$ 1 Millions
Hyperfine Inc	1.06	$ 6.924 Millions	$ 7 Millions
Pacira Biosciences inc	1.04	$ 155.154 Millions	$ 149 Millions
Humacyte Inc	1.03	$ 12.611 Millions	$ 12 Millions
Vertex Pharmaceuticals Inc	1.03	$ 1,762.800 Millions	$ 1,711 Millions
Tg Therapeutics Inc	1.03	$ 140.939 Millions	$ 137 Millions
Emergent Biosolutions Inc	1.02	$ 339.900 Millions	$ 333 Millions
Renovorx Inc	1.01	$ 0.308 Millions	$ 0 Millions

Date modified: 2026-09-04T10:26:55+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.